Guulahayada:
Sorrento waxa uu soo maray safar dheer oo ka soo bilaabmay bilow hoose ilaa uu soo helay biopharma kala duwan oo soo saarista iyo horumarinta dawada nolosha beddeleysa.
2009
La aasaasay
2013
Hantida Resiniferatoxin (RTX) ee la helay iyada oo loo marayo la wareegidda Sherrington Pharmaceuticals Inc.
Tignoolajiyada La Helay Antibody Drug Conjugation (ADC) iyada oo la helayo Concortis Biosystems Corp.
2014
PD-L1 oo shatiyeysan ka baxsan suuqa Shiinaha ee Lee's Pharm
2016
Waxa la sameeyay ImmuneOncia JV oo leh Yuhan Pharmaceuticals
La helay ZTlido® iyada oo loo marayo saamiga ugu badan ee Scilex Pharmaceuticals
Haysashada Bioserv Corporation ee hawlaha wax soo saarka cGMP
Levena Suzhou Biopharma Co. LTD oo loo sameeyay adeegyada Isku xidhka Dawooyinka Kahortagga Qofka (ADC)
2017
La helay madal Virus Oncolytic iyada oo loo sii marayo la wareegida Virttu Biologics Limited
Celularity la sameeyay Celgene iyo United Therapeutics
2018
Sofusa la helay® Nidaamka Bixinta Lymphatic ee Kimberly-Clark
2019
La helay Semnur Pharmaceuticals
Waxaa la sameeyay Scilex Holding si loo xoojiyo isku darka Scilex Pharma iyo Semnur Pharma
2020
Abivertinib oo si gaar ah shati uga haysta ACEA Therapeutics ee dhammaan calaamadaha adduunka oo dhan, marka laga reebo Shiinaha
Madal ogaanshaha HP-LAMP oo shati gaar ah u haysata oo ka socota Jaamacadda Columbia si loo ogaado coronaviruses iyo fayrasyada hargabka
La helay SmartPharm Therapeutics
2021
La helay ACEA Therapeutics
2022
La helay Virexhealth